MedTrace Logo

Smart Home-based Technology to Promote Functional Mobility Among Individuals With Parkinson's Disease

NCT05211687 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-05-17

No results posted yet for this study

Summary

Many patients with Parkinson's disease suffer of gait disorder termed as "freezing of gait" (FOG). non-pharmacological approach such as applying external cues is effective in mitigating FOG events. The aim of this study is to test the feasibility and patients satisfaction from a first stage of technology development, designed to deliver automatically external cues to the patients in their homes.

Conditions

  • Parkinson Disease

Interventions

OTHER

Smart-home for freezing of gait

A projector, Kinect camera and computer are located 2 meters from the walking area. Participants walk nine times back and forth on the walking track, in each of three walking conditions: 1. Baseline: participants walk in a comfortable pace. The walking track consist a rectangle created by a white light projected on the floor. Based on in this walking condition, step width and cadence are calculated to determine the individual parameters of the cueing. 2. Light-stripes: The walking area consist of 4-5 white light-stripes. Space between the stripes is 110% of the participant step length. Participants are instructed to walk over the stripes. 3. Metronome: The walking track consist of a rectangle created by a white light projected on the floor, and in addition metronome beats are delivered by the computer. Beats frequency are 90% of the cadence. Participants are instructed to match their steps to the metronome beats. Each walking condition up to 90 seconds.

Sponsors & Collaborators

  • Hebrew University of Jerusalem

    collaborator OTHER

  • Technion, Israel Institute of Technology

    collaborator OTHER

  • University of Haifa

    lead OTHER

Principal Investigators

  • Galit Yogev-Seligmann, PhD · University of Haifa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-12
Primary Completion
2023-03-30
Completion
2023-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211687 on ClinicalTrials.gov